Trials / Completed
CompletedNCT02244307
Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade
Evolution of Patients Suffering From Benign Prostatic Hyperplasia (BPH) Treated With Alpha-adrenergic Blockade (JOSEPHINE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,561 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this observational study was the assessment of prognosis factors for having recourse to prostatic surgery in patients with BPH who were administered class-1 alpha blockers. The secondary objectives were the assessment of the time from alpha-adrenergic blockade treatment initiation to surgery and the evolution of patients during the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | alpha-adrenergic blocker |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2003-06-01
- First posted
- 2014-09-19
- Last updated
- 2014-09-19
Source: ClinicalTrials.gov record NCT02244307. Inclusion in this directory is not an endorsement.